A Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients with Advanced or Metastatic Urothelial Carcinoma

Pavlos Msaouel, Randy F. Sweis, Manojkumar Bupathi, Elisabeth Heath, Oscar B. Goodman, Christopher J. Hoimes, Matthew I. Milowsky, Nancy Davis, Arash Rezazadeh Kalebasty, Joel Picus, David Shaffer, Shifeng Mao, Nabil Adra, Jeffrey Yorio, Sunil Gandhi, Petros Grivas, Arlene Siefker-Radtke, Rui Yang, Lisa Latven, Peter OlsonCurtis D. Chin, Hirak Der-Torossian, Amir Mortazavi, Gopa Iyer

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'A Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients with Advanced or Metastatic Urothelial Carcinoma'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry